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SN2Glutamine is a major nutrient utilized by the intestinal epithelium and is primarily assimilated via Na-
glutamine co-transport (NGcT) on the brush border membrane (BBM) of enterocytes. Recently we reported
that B0AT1 (SLC6A19) mediates glutamine absorption in villus while SN2 (SLC38A5) does the same in crypt
cells. However, how B0AT1 and SN2 are affected during intestinal inﬂammation is unknown. In the present
study it was shown that during chronic enteritis NGcT was inhibited in villus cells, however, it was stimulated
in crypt cells. Our studies also demonstrated that the mechanism of inhibition of NGcT during chronic enter-
itis was secondary to a reduction in the number of B0AT1 co-transporters in the villus cell BBM without a
change in the afﬁnity of the co-transporter. In contrast, stimulation of NGcT in crypt cells was secondary to
an increase in the afﬁnity of SN2 for glutamine without an alteration in the number of co-transporters.
Thus, glutamine assimilation which occurs via distinct transporters in crypt and villus cells is altered in the
chronically inﬂamed intestine.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Glutamine is the primary metabolite for the intestinal epithelial
cells [1] and is involved in modulation of several cell signaling path-
ways, such as induction of heat shock protein (HSP) expression [2],
regulation of redox status [3], activation of immune cells [4], inﬂu-
ence on epithelial cell apoptosis and modulation of proteome under
apoptotic conditions [5,6]. Glutamine is efﬁcacious in inhibiting
drug related toxicity and reduction of severe mucositis [7].
In the intestinal epithelial cells, glutamine can be absorbed by several
transport systems [8], among them Na-dependent co-transporters are
most important which include system A, system N and system B0 [9]. In
system A, three distinct isoforms have been cloned to date — SNAT1
(SLC38A1), SNAT2 (SLC38A2) and SNAT4 (SLC38A4) [10–14]. System N
includes two isoforms, SNAT3 (SLC38A3) and SNAT5 (SLC38A5), also
known as SN1 and SN2 respectively [15–18]. System B0 includes two dis-
tinct isoforms B0AT1 and B0AT2 [19,20]. Recently, we have demonstrated
that villus cells transport glutamine primarily via B0AT1 [21]. Further, for
theﬁrst time;we reported thepresence of nutrient absorptive transporterM, Brush Border Membrane
al Center Drive, West Virginia
6506, USA. Tel.: +1 304 293
ram).
l rights reserved.on the brush bordermembrane (BBM) of secretory crypt cells, speciﬁcally
SN2 [22].
Chronic intestinal inﬂammation is the hallmark of Crohn's disease
(CD) and ulcerative colitis (UC) collectively called inﬂammatory
bowel disease (IBD) [23]. Patients with IBD have an increased risk
of developing colorectal cancer (CRC) and the risk appears to be relat-
ed to the cumulative effect of chronic inﬂammation [24].
There is increasing evidence supporting the protective role of
glutamine supplementation to restore the health of the intestine as
nutritional therapy for IBD [25,26], but the mechanism and regulation
of NGcT during chronic intestinal inﬂammation are completely
unknown. Therefore, in this study, for the ﬁrst time, we report the
regulation of NGcT mediated by B0AT1 in villus and SN2 in crypt
cells during chronic intestinal inﬂammation.2. Materials and methods
2.1. Induction of chronic inﬂammation
Chronic intestinal inﬂammation was produced in rabbits as previ-
ously reported [27]. Pathogen-free New Zealand White male rabbits
weighing 2–2.2 kg were intragastrically inoculated with Eimeria
magna oocytes or sham inoculated with 0.9% NaCl (control animals).
All animal handling, treatments and euthanization were carried out
according to a protocol approved by the West Virginia University
IACUC.
435P. Saha et al. / Biochimica et Biophysica Acta 1818 (2012) 434–4422.2. Cell isolation
Animals were euthanized with an overdose of pentobarbital sodium
through the ear vein. Villus and crypt cells were isolated from normal
and chronically inﬂamed rabbit small intestine by a Ca++ chelation
technique as previously described [27]. Brieﬂy, a 3-ft section of ileum
was ﬁlled with buffer containing 0.15 mM EDTA, 112 mM NaCl,
25 mMNaHCO3, 2.4 mMK2HPO4, 0.4 mMKH2PO4, 2.5 mM L-glutamine,
0.5 mMβ-hydroxybutyrate, and 0.5 mMdithiothreitol, and gassedwith
95% O2, and 5% CO2, pH 7.4, at 37 °C. The intestine was incubated in this
solution for 3 min and gently palpitated for another 3 min to facilitate
cell dispersion. The ﬂuid was then drained from the ileal loop, phenyl-
methylsulfonyl ﬂuoridewas added, and the suspensionwas centrifuged
at 100 g for 3 min. Cells used for BBM vesicle (BBMV) preparation were
frozen immediately in liquid nitrogen and stored at −80 °C until
required.
2.3. Uptake studies in villus and crypt cells
Intact cell uptakes were done as previously described [27]. In brief,
villus or crypt cells (100 mg wet wt) were washed and resuspended
in HEPES buffer containing 0.2 mM glutamine, 4.5 mM KCl, 1.2 mM
KH2PO4, 1.0 mM MgSO4, 1.25 mM CaCl2, 20 mM HEPES, and either
130 mM sodium chloride or choline chloride and was gassed with
100% O2 (pH 7.4 at 37 °C). Ten μCi of 3H-glutamine was added to 1 ml
cell suspension in the HEPES buffer and 100 μl aliquots were removed
at desired time interval. The uptake was arrested at 2 min by mixing
with 10 ml ice-cold stop solution (choline-HEPES buffer). The mixture
was ﬁltered on 0.65 μm Millipore (HAWP) ﬁlters and washed twice
with ice cold-stop solution. The ﬁlter was dissolved in 5 ml Ecoscint
and the radioactivity was determined.
2.4. Na-K-ATPase measurement
Na-K-ATPase wasmeasured as Pi liberated by themethod of Forbush
[28] in cellular homogenates from the same amount of cells fromnormal
or chronically inﬂamed ileum as previously described [29]. Enzyme
speciﬁc activity was expressed as nmoles of Pi released per milligram
of protein per minute.
2.5. BBMV preparation
BBM vesicles (BBMV) from rabbit intestinal villus and crypt cells
were prepared by CaCl2 precipitation and differential centrifugation
as previously described [29]. Brieﬂy, frozen villus and crypt cells
were thawed and suspended in 2 mM Tris–HCl buffer (pH 7.0) con-
taining 50 mM mannitol. The suspension was homogenized and
CaCl2 was added to 10 mM ﬁnal concentration. The suspension was
then centrifuged at 8000 g for 15 min, and the resulting supernatant
was centrifuged at 20,000 g for 30 min. The pellet was then
suspended in 10 mM Tris–HCl buffer, pH 7.5, containing 100 mM
mannitol, and homogenized. MgSO4 was added to the suspension to
a ﬁnal concentration of 10 mM. The suspension was centrifuged at
2000 g for 15 min to remove debris, and the BBMV were collected
by centrifugation at 27,000 g for 30 min. BBMV were resuspended in
a medium appropriate to each experiment. BBMV purity was assured
with marker enzyme enrichment (e.g., alkaline phosphatase).
2.6. Uptake studies in villus and crypt cell BBMV
BBMV uptake studies were performed by the rapid-ﬁltration tech-
nique as previously described [21,22]. In brief, 5 μl of BBMV, resus-
pended in the buffer containing 100 mM choline chloride, 0.1 mM
MgSO4, 100 mM HEPES–Tris (pH 7.4), 50 mM mannitol, and 50 mM
KCl, were incubated in 95 μl of the reaction medium containing
100 mM HEPES–Tris buffer (pH 7.4), 0.2 mM glutamine, 10 μCi [3H]glutamine, 0.1 mMMgSO4, 50 mM KCl, 50 mM mannitol, and 100 mM
of either NaCl or choline chloride. Whenever pH 6.0 uptake buffer was
needed, 100 mM HEPES–Tris was replaced with 100 mM MES–Tris.
The vesicles were voltage clamped with 5.6 μM valinomycin and
15 μM carbonyl cyanide p-triﬂuoromethoxyphenylhydrazone. At
desired times, uptake was arrested by mixing with ice-cold stop solu-
tion (50 mM HEPES–Tris buffer, pH 7.4, 0.1 mM MgSO4, 50 mM KCl,
and 100 mM choline chloride). The mixture was ﬁltered on 0.45-μm
Millipore (HAWP) ﬁlters and washed twice with 5 ml of ice-cold stop
solution. Filters with BBMV were dissolved in Ecoscint scintillation
ﬂuid, and radioactivity retained on the ﬁlters was counted in a Beckman
Coulter LS 6500 liquid scintillation counter.
2.7. RTQ-PCR studies
Total RNAwas isolated from normal and chronically inﬂamed rabbit
intestinal villus and crypt cells by use of TRIzol reagent from Invitrogen
Life Technologies. Real-time quantitative PCR (RTQ-PCR) was per-
formed using total RNA isolated by a two-step method. First-strand
cDNA synthesis from total RNA was performed by using SuperScript III
from Invitrogen Life Technologies using an equal mixture of oligo(dT)
primer and random hexamers. The cDNA generated was used as tem-
plate for real-time PCR using TaqMan Universal PCR master mix from
Applied Biosystems (Foster City, CA) according to the manufacturer's
protocol. 5′-GGATCCTGCTGTGCCTCA-3′, and 5′-CGAGGTAGGGTAGCG-
TAGAAGT-3′ were the forward and reverse primer and 5′-FAM-CAC-
CATCCGCGGAATCGAGACAAC-TAMRA-3′ was the TaqMan probe for
RTQ-PCR of rabbit B0AT1. 5′-CTGGGACAGAGGGCATTC-3′, and 5′-
CGGATTTGATGATGAACAGGT-3′ were the forward and reverse primer
and 5′-FAM-CCACCGTCATCTGTCTGCACAATGTTG-TAMRA-3′ was the
TaqMan probe for RTQ-PCR of rabbit SN2. Rabbit β-actin was run along
with the B0AT1 and SN2 RTQ-PCR as an internal control by using rabbit
β-actin-speciﬁc primers and probes. The expression of β-actin was used
to normalize the expression levels of B0AT1 and SN2between the individ-
ual samples. The sequences of the rabbitβ-actin primers and probeswere
5′-GCTATTTGGCGCTGGACTT-3′, 5′-GCGGCTCGTAGCTCTTCTC-3′ and 5′-
FAM-AAGAGATGGCCACGGCCGCGAAC-TAMRA-3′. All experiments were
performed in triplicate and repeated (n=5) with RNA obtained from
separate animals. Serial dilution experiments of cDNA were performed
to establish that the efﬁciency of PCR was the same between β-actin,
B0AT1 and SN2 transporters (data not shown).
2.8. Western blot studies
Polyclonal antibody against B0AT1 was raised in goat by using the
custom antibody services provided by Invitrogen. Antigenic peptide
with the sequence-CDRFNKDIEFMIGHKPN-coupled to Keyhole limpet
hemocyanin was used as the immunogen. SN2 polyclonal antibody was
raised in chicken against antigenic peptide with the sequence CRIVPSD
TEPLFSWPK by use of the same services provided by Invitrogen. Western
blotting for B0AT1 and SN2 was performed according to the standard
protocols. Brieﬂy, plasma membranes from villus cells were solubilized
in RIPA buffer (50 mM Tris–HCl pH 7.4, 1% Igepal, 150 mM NaCl, 1 mM
EDTA, 1 mM PMSF, 1 mM Na3VO4, 1 mM NaF) containing protease
inhibitor cocktail (Sigma-Aldrich, St. Louis, MO). Equal volume of 2x
SDS/sample buffer (100 mMTris, 25% glycerol, 2% SDS, 0.01% bromphenol
blue, 10% 2-ME, pH 6.8) was added and the proteins were separated on a
4–20% Ready Gel (Bio-Rad Laboratories, Hercules, CA). The separated
proteins were transferred on to polyvinylidene diﬂuoride membrane
and probed with the primary antibody against rabbit B0AT1 and SN2
overnight at 4 °C. Secondary antibodies coupled to horseradish peroxi-
dase were used to monitor the binding of the primary antibody. ECL
Western blotting detection reagent (GE Healthcare Bio-Sciences, Piscat-
away, NJ)was used to detect the B0AT1 and SN2 speciﬁc signal. The resul-
tant chemiluminescent signals were quantitated by using a Molecular
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performed in triplicate.
2.9. Immuno-localization of B0AT1 and SN2 in the rabbit small intestine
and enterocytes
Immunolocalization of B0AT1 and SN2 protein in the normal and
chronically inﬂamed rabbit small intestine was determined by immu-
nohistochemistry (IHC) technique. Normal and chronically inﬂamed
rabbit intestinal tissue was ﬁxed in 10% (vol/vol) neutral-buffered for-
malin (Richard-Allan Scientiﬁc, Kalamazoo, MI) and embedded in par-
afﬁn. Sections measuring 4 μm thick were made using a microtome
and mounted on glass slides. Parafﬁn was removed from the sections
by incubating the slides with xylene, and sections were hydrated grad-
ually by incubating in graded ethanol. Antigen retrieval was performed
by incubating the sections with 10 mM sodium citrate buffer, pH 6, at
95 °C for 5 min. Nonspeciﬁc binding sites in the tissue sections were
blocked by incubation with bovine and goat serum for B0AT1 and SN2
respectively for 1 h at room temperature. The tissue sections were
then incubated overnightwith B0AT1 and SN2primary antibody. Excess
antibody was removed by washing with PBS. Sections were then incu-
bated with bovine anti-goat IgG secondary antibody coupled to tetra-
methyl rhodamine isothiocyanate (TRITC; Santa Cruz Biotechnology,
Santa Cruz, CA) and goat anti-chicken IgG secondary antibody coupled
to FITC (Santa Cruz Biotechnology, Santa Cruz, CA) at room temperature
for 1 h. Excess secondary antibody was removed by washing with PBS
and the tissue sections were mounted with ProLong Gold Antifade
Reagent (Invitrogen Life Technologies). Finally, the signal generated
by TRITC and FITC was observed under Zeiss LSM510 confocal micro-
scope and photographed. Localization of B0AT1 and SN2 in the isolatedFig. 1. Effect of chronic intestinal inﬂammation on Na-glutamine co-transport. A. Na-dep
cells from the chronically inﬂamed intestine (173±6.3 in normal; 81.4±1.8 pmol/mg pr
3H-glutamine uptake is signiﬁcantly increased in crypt cells during chronic enteritis (53
intestine, n=3, *pb0.01). C. Na-K-ATPase which provides the favorable Na gradient for
intestine (13.5±0.5 nmol/mg protein.min in normal villus cells; 6.7±0.3 in inﬂamed, n=4
inﬂamed intestine (6±0.4 nmol/mg protein.min in normal; 11.8±0.5 during chronic entevillus and crypt cells from the normal and inﬂamed intestine was per-
formed using the same method except that the cells were ﬁxed in 4%
paraformaldehyde and permeabilized in chilled methanol for 10 s.
2.10. Data presentation
When data were averaged means±SE were shown, except when
error bars are inclusive within the symbol. All uptakes and RTQ-PCR
were done in triplicates. The number (n) for any set of experiments refers
to numbers of rabbits. Student's t-test was used for statistical analysis.
3. Results
3.1. Whole cell glutamine uptake
In villus cells from the chronically inﬂamed intestine, NGcT was
signiﬁcantly reduced in comparison to villus cells from normal rabbit
intestine (Fig. 1A). In contrast, in crypt cells during chronic enteritis
NGcT was signiﬁcantly increased (Fig. 1B). The alteration of NGcT
during chronic intestinal inﬂammation may be either secondary to
altered cellular Na gradient or at the level of the Na-glutamine
co-transporter in the BBM or both. Since Na-K-ATPase provides the
favorable Na gradient for NGcT, we measured Na-K-ATPase activity.
3.2. Na-K-ATPase activity
In villus cells from the chronically inﬂamed intestine, Na-K-ATPase
activity was signiﬁcantly inhibited (Fig. 1C) while it was signiﬁcantly
increased in crypt cells compared to normal (Fig. 1D). Thus, inhibition
of NGcT in villus cells and stimulation in crypt cells during chronicendent 3H-glutamine uptake (pmol/mg protein) is signiﬁcantly diminished in villus
otein.2 min in villus cells from inﬂamed intestine, n=3, *pb0.01). B. Na-dependent
.9±2.7 pmol/mg protein.2 min in normal; 133.5±13.5 in crypt cells from inﬂamed
Na-glutamine co-transport is decreased in villus cells from the chronically inﬂamed
, *pb0.01). D. Na-K-ATPase is signiﬁcantly increased in crypt cells from the chronically
ritis, n=4, *pb0.01).
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ity of cells. We then determined if NGcT was directly affected at the
co-transporter level in the BBM of villus and crypt cells.
3.3. BBM vesicle (BBMV) glutamine uptake in villus and crypt cells
NGcTwas signiﬁcantly decreased in villus cell BBMV (Fig. 2A) but in-
creased in crypt cell BBMV during chronic intestinal inﬂammation
(Fig. 2B). These results indicate that the alteration of the NGcT during
chronic intestinal inﬂammation is secondary to an alteration at the
level of co-transporter in the villus and crypt cell BBM.
3.4. BBM vesicle (BBMV) glutamine uptake in all enterocytes
To determine whether during intestinal inﬂammation there is an
overall net Na-dependent glutamine co-transport inhibition, stimula-
tion or no change, we looked at uptake in all enterocytes from normal
and chronically inﬂamed intestine. BBMV uptake of enterocytes in
normal was 200±16.8 pmol/mg protein·30 s and in chronically
inﬂamed it was 77±8.4 pmol/mg protein·30 s, (n=3, pb0.003).
These results indicate that despite an apparent attempt at compensa-
tion by the crypt cell, there is net overall Na-dependent glutamine
uptake inhibition in the chronically inﬂamed intestine as compared
to the normal. To determine the mechanism of these alterations we
performed kinetic studies.
3.5. Kinetic studies
Kinetic studies demonstrated that the mechanism of inhibition of
NGcT in villus cells was secondary to a reduction in the maximal rateFig. 2. BBMV studies of NGcT during chronic intestinal inﬂammation. The Na-dependent glu
extracellular Na minus uptake in the absence of extracellular Na. A. Na-dependent glutamin
intestine at all time points measured (n=3, *pb0.05). B. In contrast, Na-dependent gluta
inﬂammation (n=3, *pb0.05). C. Kinetic studies of glutamine uptake of villus BBMV from t
from 4 different animals. The ﬁgure shows Na-dependent glutamine uptake as a function of
glutamine was increased, the uptake of glutamine was stimulated and subsequently becam
Analysis of the data by Michaelis–Menton equation yielded the kinetic parameters. In villus
mg protein.6 s in normal; 1.75±0.1 pmol/mg protein.6 s in inﬂamed, n=3, *pb0.05). Howe
D. Kinetics of glutamine uptake in crypt cell BBMV from the normal and inﬂamed intestine
protein.6 s in normal, 1.9±0.1 pmol/mg protein.6 s in inﬂamed). However, the afﬁnity (Km
normal; 18.07±1.6 mM in inﬂamed, (n=3, *pb0.05).of uptake (Vmax) without a change in the afﬁnity (Fig. 2C). However,
in crypt cells the mechanism of stimulation of NGcT was secondary to
increased afﬁnity (1/Km) for glutamine without a change in the Vmax
(Fig. 2D). These studies indicate that the mechanism of inhibition of
NGcT in villus cells is likely secondary to reduced co-transporter num-
bers, while the mechanism of stimulation of NGcT in crypt cells during
chronic enteritis is likely secondary to enhanced afﬁnity of the
co-transporters for glutamine.
Our laboratory has shown in previous studies that B0AT1 and SN2
are responsible for Na-glutamine co-transport in villus and crypt cells
respectively [21,22]. Thus, to explore the mechanism of alteration at
the level of the speciﬁc co-transporter we performedmolecular studies.
3.6. Relative abundance of B0AT1 and SN2 mRNA
To determine the molecular mechanisms of alterations of B0AT1
and SN2 we quantiﬁed mRNA abundance by RTQ-PCR. The abundance
of B0AT1 mRNA in villus cells and SN2 mRNA in crypt cells was found
to be reduced during chronic enteritis (Fig. 3A and B).
3.7. Quantitation of B0AT1 and SN2 protein in BBM
Since mRNA levels may not necessarily correlate with protein in
the BBM, Western blot analyses of B0AT1 and SN2 protein were
performed on extracts of BBM. B0AT1 protein levels were markedly
diminished in villus cell BBM during chronic enteritis (Fig. 3C) and
this was conﬁrmed by densitometric quantitation (Fig. 3E). In
contrast, in crypt cell BBM, SN2 was unaffected during chronic intes-
tinal inﬂammation (Fig. 3D and F). For loading control we analyzed
the expression of Ezrin using mouse anti Ezrin monoclonal antibody.tamine uptake was determined as a function of 3H-glutamine uptake in the presence of
e uptake was signiﬁcantly decreased in villus cell BBMV from the chronically inﬂamed
mine uptake was signiﬁcantly increased in crypt cell BBMV during chronic intestinal
he normal and inﬂamed intestine. The ﬁgure is representative of 4 BBMV experiments
varying concentrations of extracellular glutamine. As the concentration of extracellular
e saturated in the villus cell BBMV from the normal and chronically inﬂamed intestine.
cells the maximal rate of uptake (Vmax) was signiﬁcantly diminished (3.7±0.3 pmol/
ver, the afﬁnity was unchanged (24.6±2.8 mM in normal; 26.7±4.3 mM in inﬂamed).
. In crypt cells the maximal rate of uptake (Vmax) was not altered (2.2±0.2 pmol/mg
) was increased signiﬁcantly during chronic intestinal inﬂammation (51.8±3.2 mM in
Fig. 3. Effect of chronic intestinal inﬂammation on B0AT1 and SN2mRNA and protein. A. In villus cells, B0AT1mRNA expression quantitated by RTQ-PCRwas signiﬁcantly reduced during
chronic intestinal inﬂammation (n=5, *pb0.05). B. SN2 mRNA abundance was also decreased in crypt cells during chronic enteritis. The expression of mRNA was normalized using
β-actin in all conditions. Since, mRNA levels may not correlate with functional protein levels, immunoreactive protein levels of B0AT1 and SN2 were measured in villus and crypt cell
BBM C. Representative ﬁgure of B0AT1Western blot from 3 independent experiments eachwith different animals. B0AT1 protein ismarkedly diminished in villus cell BBM during chronic
enteritis. D. In contrast, in crypt cells SN2 protein levels were unaffected in the BBM during chronic intestinal inﬂammation. Ezrin was used as loading control for all conditions. E and F.
Densitometric quantitation of Western blots of villus and crypt cells respectively conﬁrmed the observations shown in panels C and D.
Fig. 4. SN2 protein stability. Down regulation of SN2 mRNA expression and unchanged
SN2 protein level at BBMmay indicate increased stability of existing protein on BBM. A.
Representative Western blot of SN2 in normal and inﬂamed crypt cells which were
treated with protein synthesis inhibitor cycloheximide (15 μg/ml) in-vitro for 24 h.
As expected cycloheximide decreased SN2 protein expression in crypt cells from the
normal but not from the chronically inﬂamed intestine. B. Densitometric quantitation
conﬁrmed these ﬁndings. Thus, these data indicate that the stability of SN2 protein is
increased in crypt cells BBM during chronic inﬂammation.
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in tandem during chronic enteritis. In contrast, SN2 mRNA expression
was decreased in the crypt cell whereas the protein level in BBM
remained unchanged during inﬂammation. This may either be due
to increased de novo protein synthesis or increased stability of the
existing protein in the BBM during chronic inﬂammation. To examine
the mechanism, we treated the crypt cells with protein synthesis
inhibitor cycloheximide (15 μg/ml) in-vitro for 24 h. We measured
lactate dehydrogenase activity to assess the extent of cytotoxicity of
cycloheximide treatment and observed that the cell viability was
not signiﬁcantly affected in the treated cells (data not shown). Cyclo-
heximide treatment signiﬁcantly inhibited the expression of SN2
(~50%) in the crypt cells isolated from normal rabbit intestine, but
there was no signiﬁcant change in SN2 expression between inﬂamed
and inﬂamed cycloheximide-treated cells (Fig. 4A and B). These
observations indicate that the stability of SN2 protein is increased
during chronic inﬂammation in the BBM of the crypt cells which helps
to maintain its level in the BBM despite decreased mRNA levels.
3.8. Localization of B0AT1 and SN2 along the villus-crypt axis
Previous immunohistochemical studies demonstrated the presence
of B0AT1 along the villus, whereas SN2 was present in the crypts in
the normal rabbit small intestine [21,22]. In the chronically inﬂamed in-
testine B0AT1 expression is signiﬁcantly diminished in the villus region
(Fig. 5A and B). In contrast, SN2 expression is increased inmultiple rows
Fig. 5. Distribution of B0AT1 and SN2 along the intestinal villus-crypt axis. A. B0AT1 expression is robustly demonstrated along the villus axis in the normal intestine. B. B0AT1
expression is diminished in the chronically inﬂamed intestine. C. In contrast, SN2 is only expressed in the crypt region in normal intestine. D. SN2 expression is increased in multiple
rows of crypts cells in chronically inﬂamed intestine. E. Co-localization of both B0AT1 and SN2 demonstrates the unique distribution along the villus-crypt axis in the normal intestine.
F. Co-localization studies conﬁrmed the alterations in B0AT1 and SN2 along villus-crypt axis in the chronically inﬂamed intestine.
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occur during chronic enteritis [30] as compared to the normal intestine
(Fig. 5C). Co-localization of both B0AT1 and SN2 with our custom anti-
bodies demonstrated their unique distribution in the normal intestine
in Fig. 5E and their alterations during chronic enteritis in Fig. 5F. These
results indicate that B0AT1 protein level is markedly decreased along
the villus axis during chronic enteritis. However, SN2 is increased in
crypt region due to the increased number of crypt cells during chronic
enteritis. To analyze the amount of B0AT1 and SN2 in individual villus
and crypt cells we performed immunocytochemistry.3.9. Expression of B0AT1 in villus and SN2 in crypt cells
Immunocytochemical studies were performed using isolated villus
and crypt cells from normal and chronically inﬂamed rabbit intestine.
B0AT1 is distinctly expressed in the BBM of normal villus cells
(Fig. 6A) and it is signiﬁcantly diminished in these cells from the chron-
ically inﬂamed intestine (Fig. 6B and C). SN2 is expressed in the BBM of
crypt cells isolated from the normal intestine (Fig. 6D); however, it
remains unaffected in these cells from the chronically inﬂamed intes-
tine (Fig. 6E and F). These studies indicate that B0AT1 is markedly
Fig. 6. Immunocytochemisty of B0AT1 in villus cell and SN2 in crypt cells. To quantitate B0AT1 and SN2 protein at the BBM, immunocytochemistry was performed in isolated villus
and crypt cells. A. Representative villus cell demonstrating that B0AT1 is distinctly expressed in the BBM of normal intestine. B. B0AT1 expression is diminished in villus cells from
the chronically inﬂamed intestine. C. Densitometric analysis showed that the alteration is signiﬁcant (n=6, *pb0.05). D. Representative crypt cell demonstrating that SN2 is
expressed only in the BBM in the normal intestine. E. SN2 expression is unchanged in the BBM of crypt cells from the chronically inﬂamed intestine. F. Densitometric quantitation
conﬁrmed these ﬁndings. These data indicate that B0AT1 is present in the BBM of villus cells and that it is markedly diminished during chronic intestinal inﬂammation. In contrast,
SN2 is present in the BBM of crypt cells and its levels are unaffected in the chronically inﬂamed intestine.
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from the chronically inﬂamed intestine.
4. Discussion
The signiﬁcance of the amino acid glutamine for the normal growth
and differentiation of intestinal enterocytes, as well as for numerous
other critical functions has been well documented. Our laboratory has
previously demonstrated that Na dependent co-transport pathways fa-
cilitate glutamine absorption but through different co-transporters in
the villus and the crypt cells [21,22]. In the rabbit small intestine we
reported that Na-glutamine co-transport is facilitated by B0AT1 in the
BBM of villus cells, while in the crypt cells it is facilitated by SN2 [22].
While the assimilation of glutamine may be important to maintain the
normal health of the small intestinal mucosa it may play a more vital
role in chronic pathophysiological conditions to help restore the muco-
sal integrity and function. Thus, we studied how glutamine assimilation
may be regulated in a mammalian model of chronic small intestinal
inﬂammation.
NGcTmediated by B0AT1 in villus cells was inhibited during chronic
intestinal inﬂammation. The mechanism of inhibitionwas secondary to
both an altered Na extruding capacity of the villus cells as well as a
direct effect at the level of the co-transporter on the BBM. At the level
of the co-transporter, B0AT1 was inhibited secondary to a reduction in
the co-transporter numbers on the BBM. This is most likely transcrip-
tion mediated as reﬂected by a decrease in the steady state mRNA of
B0AT1 in villus cells from the chronically inﬂamed intestine. In contrast,
in crypt cells from the chronically inﬂamed intestine NGcTmediated by
SN2 was signiﬁcantly increased. This increase was also at least in part
secondary to the altered Na-K-ATPase activity in the basolateral mem-
brane of these cells. Nevertheless at the level of the co-transporter,
SN2was also directly affected in the crypt cells during chronic intestinal
inﬂammation. The mechanism of stimulation of SN2 was found to besecondary to an increase in the afﬁnity of co-transporter for glutamine
without a change in the number of co-transporters. Chronic intestinal
inﬂammation leads to villus atrophy, crypt hyper proliferation and a
variety of biochemical and functional abnormalities especially electrolyte
and nutrient malabsorption.
Previous reports from our lab and others have shown signiﬁcant inhi-
bition of electrolyte [31,32], glucose [29], alanine [33], bile acid [34] and
peptide [35] transport in villus cells during chronic intestinal inﬂamma-
tion. Several novel observations were made in the course of this study.
NGcT villus cells were inhibited by a mechanism that appears to be
unique to glutamine among other amino acids. For example,wehave pre-
viously demonstrated that sodium neutral amino acids co-transport, spe-
ciﬁcally sodium alanine co-transport, mediated by ATB0 in villus cells in
the rabbit small intestine was inhibited secondary to a decrease in the af-
ﬁnity of the co-transporter for alanine without change in the co-
transporter numbers [33]. Similarly, in rat intestinal epithelial cells, we
demonstrated that the sodium alanine co-transport mediated by ASCT1
was inhibited by a chronic immune inﬂammatory mediator LTD4, also
by decreasing the afﬁnity of the co-transporter for alanine without a
change in the number of co-transporters [36]. Further, we had also dem-
onstrated that H+-dipeptide co-transport in rabbit intestinal villus cells
was also inhibited during chronic intestinal inﬂammation secondary to
a decrease in the afﬁnity of the co-transporter for the dipeptide without
a change in the number of co-transporters on the BBM [35]. In contrast,
Na glutamine co-transport in villus cells is inhibited secondary to a de-
crease in co-transporter number, but not afﬁnity of the transporter to its
substrate during chronic enteritis. Thus, B0AT1 appears to be uniquely
regulated during chronic intestinal inﬂammation.
Though, folate and thiamine transports have shown to be present in
mouse crypt cells [37,38], NGcT mediated by SN2 is the only absorptive
transport pathway to be demonstrated in otherwise secretory crypt
cells of the rabbit small intestine. While all the other sodium solute co-
transport pathways present only on the BBM of villus cells have been
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testinal inﬂammation, the Na-glutamine co-transporter SN2 found in the
BBM of crypt cells, in contrast is stimulated during chronic enteritis.
Further, while NGcTmediated by B0AT1 in villus cells is inhibited second-
ary to decrease in co-transporter numbers, the same transport process
mediated by SN2 in the crypt cells is stimulated secondary to an alteration
in the afﬁnity and increase in protein stability of the co-transporter with-
out a change in the number of the BBM co-transporters. The increased
stability of the SN2 protein seen during inﬂammation, may be a result of
changes in the phosphorylation or nitrosylation levels of the protein itself
which could be mediated by a multiple of immune inﬂammatory media-
tor or cell signaling pathways. Therefore, the exact mechanism of
alteration of the SN2 protein and immune-inﬂammatory mediators that
may be responsible for these alterations are to be elucidated.
It is conceivable that crypt hypertrophy and stimulation of SN2 in
crypt cells are compensatory mechanisms to offset the loss of gluta-
mine absorption due to villus atrophy and inhibition of B0AT1 during
chronic intestinal inﬂammation [39–43]. But, the stimulation of gluta-
mine absorption by the crypt cells does not satisfy the overall demand
for glutamine by the enterocytes. This is likely because the villus ab-
sorptive area (BBM) is much, much greater than that of the crypt,
on the order of 1000–10,000×, so the relative number of transporters
in toto will still be strongly biased in the direction of the villus thus,
accounting for the observed inhibition of overall glutamine uptake.
As glutamine is critical for intestinal epithelial growth and differentia-
tion, better understandingof the immune regulation of glutamine absorp-
tion during chronic intestinal inﬂammation may lead to more efﬁcacious
and novel nutritional treatments for IBD. Further, there is increasing
evidence in supporting a protective role of glutamine supplementation
during DMBA induced carcinogenesis [44,45], cancer progression and
chemotherapy efﬁcacy [46], in postoperative complication in CRC surgery
[47]. It has also been reported that SN2 expression is upregulated in can-
cerous tissues from eye, kidney, head and neck, in contrast, neoplastic
tissues did not exhibit increased expression of SN2 [48]. Thus it could be
speculated that NGcT SN2 may be a potent therapeutic target for regula-
tion of the process of carcinogenesis.
In conclusion, multiple novel observations have resulted from this
study. NGcT mediated by B0AT1 in villus and SN2 in crypt cells is
altered in chronically inﬂamed intestine. While B0AT1 was reduced in
villus, SN2 was increased in crypt cells during chronic enteritis. The
mechanism of these alterations was also distinct— B0AT1was inhibited
secondary to a reduction in mRNA expression and the number of co-
transporters while SN2 was increased secondary to an apparent in-
crease in the afﬁnity of the co-transporters. Thus, glutamine assimila-
tion is uniquely regulated in the chronically inﬂamed intestine.
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